[Soft tissue sarcomas: Questions about reported clinical benefit]

Bull Cancer. 2015 Oct;102(10):804-5. doi: 10.1016/j.bulcan.2015.06.005. Epub 2015 Sep 15.

[Article in French]

Authors

Nicolas Penel¹, Sophie Cousin², Nuria Kotecki²

Affiliations

¹ Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France. Electronic address: [email protected].
² Centre Oscar-Lambret, département de cancérologie générale, 3, rue Combemale, 59020 Lille cedex, France.

PMID: 26384692
DOI: 10.1016/j.bulcan.2015.06.005

No abstract available

Publication types

Congress
News

MeSH terms

Antibodies, Monoclonal / therapeutic use
Antineoplastic Agents / therapeutic use*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Clinical Trials as Topic
France
Humans
Sarcoma / drug therapy*
Sarcoma / pathology

Substances

Antibodies, Monoclonal
Antineoplastic Agents